Clinical Trials Logo

Clinical Trial Summary

Irregular menstrual cycles are common in girls for several years after their first menstrual period. The cause of abnormal menstrual cycles during this time is not well-understood. The purpose of this study is to: 1) monitor girls during a menstrual cycle (with blood and urine sampling and serial pelvic ultrasounds) to identify those girls who do not ovulate (release of an egg from the ovary), and 2) determine whether cycles can be corrected by treating girls with a short course of low-dose estrogen and progesterone.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02486757
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Completed
Phase Early Phase 1
Start date April 2015
Completion date March 1, 2016

See also
  Status Clinical Trial Phase
Completed NCT00195559 - Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder Phase 3
Not yet recruiting NCT05948358 - The Menstrual Distress Questionnaire (MEDI-Q) Reliability and Validity of the Turkish Version
Terminated NCT01183377 - Frequency of Female Athlete Triad Among Elite Female Athlete of Iran in Different Sport in 2007 N/A
Not yet recruiting NCT04583943 - Lifestyle Influence on Primary Dysmenorrhea
Completed NCT05928650 - Comparison of Menstrual Function Among Sprinters, Long Marathon Runners, and Non-Athletic Females
Completed NCT04938622 - Bioenergetics of Exercise-Induced Menstrual Disturbances N/A
Completed NCT05107804 - Energy Restriction and Hormones in Premenopausal Women N/A
Recruiting NCT06297980 - Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes N/A
Completed NCT02070692 - Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users Phase 4
Active, not recruiting NCT01103518 - Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation Phase 4
Completed NCT00128934 - Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder Phase 3
Completed NCT00001259 - A Treatment Study for Premenstrual Syndrome (PMS) Phase 1
Withdrawn NCT00357981 - Continuous Use of the Contraceptive Patch and the Personal Economic Impact. N/A